Cargando…
Aging Model for Analyzing Drug-Induced Proarrhythmia Risks Using Cardiomyocytes Differentiated from Progeria-Patient-Derived Induced Pluripotent Stem Cells
Among various cardiac safety concerns, proarrhythmia risks, including QT prolongation leading to Torsade de Pointes, is one of major cause for drugs being withdrawn (~45% 1975–2007). Preclinical study requires the evaluation of proarrhythmia using in silico, in vitro, and/or animal models. Consideri...
Autores principales: | Daily, Neil, Elson, Julian, Wakatsuki, Tetsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418415/ https://www.ncbi.nlm.nih.gov/pubmed/37569335 http://dx.doi.org/10.3390/ijms241511959 |
Ejemplares similares
-
Deep Learning-Based Proarrhythmia Analysis Using Field Potentials
Recorded From Human Pluripotent Stem Cells Derived
Cardiomyocytes
Publicado: (2019) -
On-chip spatiotemporal electrophysiological analysis of human stem cell derived cardiomyocytes enables quantitative assessment of proarrhythmia in drug development
por: Asahi, Yumiko, et al.
Publicado: (2018) -
Effect of hydroxychloroquine on proarrhythmia risk assessment using human iPSC-derived cardiomyocytes
por: Yanagida, Shota, et al.
Publicado: (2021) -
Proarrhythmia Induced by Propafenone: What is the Mechanism?
por: Femenia, Francisco, et al.
Publicado: (2010) -
Exosomes From Induced Pluripotent Stem Cell–Derived Cardiomyocytes Promote Autophagy for Myocardial Repair
por: Santoso, Michelle R., et al.
Publicado: (2020)